secwatch.observer — SEC 8-K summary
======================================

Issuer:     TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)
CIK:        0000818686
Form:       8-K
Filed at:   2025-05-28T23:59:59+00:00
Accession:  0001193125-25-129488
Event type: debt
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Teva issues €1B and $1.2B in senior notes to refinance debt, upsizes tender offer to $2.25B
--------------------------------------------------------------------------------

- €1B of 4.125% Senior Notes due 2031; $500M of 6.000% notes due 2032; $700M of 5.750% notes due 2030.
- Net proceeds fund tender offer for up to $2.25B (upsized from $2B) and repay other outstanding debt.
- Notes are senior unsecured obligations guaranteed by Teva; customary covenants and events of default.
- Issuance made under Teva's existing shelf registration statement filed February 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/818686/000119312525129488/0001193125-25-129488-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/818686/000119312525129488/d918164d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-129488

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer